Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$230.21 USD
+6.73 (3.01%)
Updated May 26, 2022 04:00 PM ET
After-Market: $230.14 -0.07 (-0.03%) 6:00 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Detailed Estimates
Estimates
Exp Earnings Date | 8/3/22 |
---|---|
Current Quarter | 2.83 |
EPS Last Quarter | 2.75 |
Last EPS Surprise | 1.48% |
ABR | 1.41 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 11.63 |
Next Year | 13.39 |
EPS (TTM) | 10.55 |
P/E (F1) | 19.21 |
Sales Estimates
Current Qtr (6/2022) |
Next Qtr (9/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.01B | 1.03B | 4.05B | 4.50B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 1.03B | 1.05B | 4.07B | 4.56B |
Low Estimate | 990.14M | 1.02B | 4.02B | 4.40B |
Year ago Sales | 914.61M | 895.94M | 3.54B | 4.05B |
Year over Year Growth Est. | 10.97% | 15.27% | 14.39% | 11.04% |
Earnings Estimates
Current Qtr (6/2022) |
Next Qtr (9/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.83 | 2.94 | 11.63 | 13.39 |
# of Estimates | 6 | 6 | 8 | 8 |
Most Recent Consensus | 2.85 | 2.86 | 11.46 | 12.77 |
High Estimate | 2.89 | 3.04 | 11.75 | 13.70 |
Low Estimate | 2.80 | 2.78 | 11.46 | 12.77 |
Year ago EPS | 2.61 | 2.70 | 10.32 | 11.63 |
Year over Year Growth Est. | 8.43% | 8.89% | 12.69% | 15.13% |
Agreement - Estimate Revisions
Current Qtr (6/2022) |
Next Qtr (9/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 2 | 3 |
Up Last 60 Days | 2 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 5 | 2 | 4 |
Down Last 60 Days | 3 | 5 | 2 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2022) |
Next Qtr (9/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Current | 2.83 | 2.94 | 11.63 | 13.39 |
7 Days Ago | 2.83 | 2.94 | 11.63 | 13.39 |
30 Days Ago | 2.85 | 2.98 | 11.63 | 13.42 |
60 Days Ago | 2.83 | 3.00 | 11.64 | 13.51 |
90 Days Ago | 2.83 | 3.00 | 11.64 | 13.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2022) |
Next Qtr (9/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.83 | 2.93 | 11.63 | 13.39 |
Zacks Consensus Estimate | 2.83 | 2.94 | 11.63 | 13.39 |
Earnings ESP | 0.00% | -0.32% | -0.01% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2022) |
Quarter Ending (12/2021) |
Quarter Ending (9/2021) |
Quarter Ending (6/2021) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.75 | 2.49 | 2.70 | 2.61 | NA |
Estimate | 2.71 | 2.42 | 2.57 | 2.39 | NA |
Difference | 0.04 | 0.07 | 0.13 | 0.22 | 0.12 |
Surprise | 1.48% | 2.89% | 5.06% | 9.21% | 4.66% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more